Khalil Ansarin

416 total citations
12 papers, 241 citations indexed

About

Khalil Ansarin is a scholar working on Infectious Diseases, Molecular Biology and Neurology. According to data from OpenAlex, Khalil Ansarin has authored 12 papers receiving a total of 241 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Infectious Diseases, 3 papers in Molecular Biology and 3 papers in Neurology. Recurrent topics in Khalil Ansarin's work include COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Khalil Ansarin is often cited by papers focused on COVID-19 Clinical Research Studies (4 papers), Long-Term Effects of COVID-19 (3 papers) and SARS-CoV-2 and COVID-19 Research (2 papers). Khalil Ansarin collaborates with scholars based in Iran, United States and Australia. Khalil Ansarin's co-authors include Saeid Safiri, Ali Taghizadieh, Kristin Carson‐Chahhoud, Ali‐Asghar Kolahi, Seyed Aria Nejadghaderi, Mohammadreza Ardalan, Parviz Saleh, Mojtaba Varshochi, Shahnam Arshi and Kenneth R. Chapman and has published in prestigious journals such as SHILAP Revista de lepidopterología, CHEST Journal and Reviews in Medical Virology.

In The Last Decade

Khalil Ansarin

11 papers receiving 237 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khalil Ansarin Iran	7	137	46	42	36	30	12	241
Luis Unigarro Ecuador	3	176 1.3×	61 1.3×	28 0.7×	31 0.9×	11 0.4×	5	308
Doménica Cevallos-Robalino Ecuador	4	178 1.3×	60 1.3×	27 0.6×	30 0.8×	11 0.4×	5	314
Sebastiano Macheda Italy	8	107 0.8×	79 1.7×	33 0.8×	36 1.0×	41 1.4×	15	247
Anis Abobaker Libya	6	137 1.0×	60 1.3×	25 0.6×	23 0.6×	8 0.3×	12	275
Md. Asad Ullah Bangladesh	5	71 0.5×	43 0.9×	87 2.1×	29 0.8×	8 0.3×	6	282
Tungki Pratama Umar Indonesia	8	73 0.5×	23 0.5×	54 1.3×	12 0.3×	19 0.6×	61	239
Ramazan Sabırlı Türkiye	10	183 1.3×	80 1.7×	74 1.8×	24 0.7×	16 0.5×	23	328
W. X. Gong China	6	290 2.1×	96 2.1×	71 1.7×	20 0.6×	8 0.3×	16	414
Maheswari Kulandhasamy India	8	218 1.6×	99 2.2×	49 1.2×	12 0.3×	9 0.3×	17	296
Isabel Mur Spain	8	144 1.1×	53 1.2×	31 0.7×	17 0.5×	9 0.3×	13	235

Countries citing papers authored by Khalil Ansarin

Since Specialization

Citations

This map shows the geographic impact of Khalil Ansarin's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Ansarin with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Ansarin more than expected).

Fields of papers citing papers by Khalil Ansarin

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Ansarin. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Ansarin. The network helps show where Khalil Ansarin may publish in the future.

Co-authorship network of co-authors of Khalil Ansarin

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Ansarin. A scholar is included among the top collaborators of Khalil Ansarin based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Ansarin. Khalil Ansarin is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

12 of 12 papers shown

Ghorbaninezhad, Farid, Nima Hemmat, Khalil Ansarin, et al.. (2022). Hemoperfusion Therapy’s Efficiency in Reducing Serum IL-6 Levels and Disease Severity in COVID-19 Patients. SHILAP Revista de lepidopterología. 2. 10–10.

Ansarin, Khalil, et al.. (2022). The effect of Fingolimod on patients with moderate to severe COVID‐19. Pharmacology Research & Perspectives. 11(1). e01039–e01039. 13 indexed citations

Safiri, Saeid, Kristin Carson‐Chahhoud, Nahid Karamzad, et al.. (2021). Prevalence, Deaths, and Disability-Adjusted Life-Years Due to Asthma and Its Attributable Risk Factors in 204 Countries and Territories, 1990-2019. CHEST Journal. 161(2). 318–329. 49 indexed citations

Ansarin, Khalil, et al.. (2021). Comparison of spirometry and impulse oscillometry in methacholine challenge test for the detection of airway hyperresponsiveness in adults. Tuberkuloz ve Toraks. 69(1). 1–8. 4 indexed citations

Noori, Maryam, Seyed Aria Nejadghaderi, Kristin Carson‐Chahhoud, et al.. (2021). ABO blood groups and risk of human immunodeficiency virus infection: A systematic review and meta‐analysis. Reviews in Medical Virology. 32(3). e2298–e2298. 4 indexed citations

Noori, Maryam, Seyed Aria Nejadghaderi, Shahnam Arshi, et al.. (2021). Potency of BNT162b2 and mRNA‐1273 vaccine‐induced neutralizing antibodies against severe acute respiratory syndrome‐CoV‐2 variants of concern: A systematic review of in vitro studies. Reviews in Medical Virology. 32(2). e2277–e2277. 46 indexed citations

Mikaeili, Haleh, Ali Taghizadieh, Masoud Nazemiyeh, et al.. (2021). The early start of hemoperfusion decreases the mortality rate among severe COVID‐19 patients: A preliminary study. Hemodialysis International. 26(2). 176–182. 13 indexed citations

Nouri‐Vaskeh, Masoud, Ramin Zand, Mojtaba Varshochi, et al.. (2021). Comparison of losartan and amlodipine effects on the outcomes of patient with COVID‐19 and primary hypertension: A randomised clinical trial. International Journal of Clinical Practice. 75(6). e14124–e14124. 26 indexed citations

Ansarin, Khalil, Ramin Tolouian, Mohammadreza Ardalan, et al.. (2020). Effect of bromhexine on clinical outcomes and mortality in COVID-19 patients: A randomized clinical trial. Bioimpacts. 10(4). 209–215. 73 indexed citations

10.

Samadi, Nasser, et al.. (2020). Phosphorylation Modulates Survivin Function in Behcet’s Disease. Advanced Pharmaceutical Bulletin. 10(2). 278–283. 9 indexed citations

11.

Ansarin, Khalil, et al.. (2013). Review of Exhaled Biomarkers in Different Pulmonary Diseases. Medical Journal of Tabriz University of Medical Sciences and Health Services. 35(4). 96–105. 3 indexed citations

12.

Ansarin, Khalil, et al.. (2008). Comparison Study of Cyfra 21-1, Carcinoembryonic Antigen and Telomerase Activity between Non Small Cell and Small Cell Lung Cancer Patients. SHILAP Revista de lepidopterología. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact